Tag: disease modifying therapies
El MSIF pone el foco en el uso ético de las terapias modificadoras de la enfermedad no indicadas en la etiqueta para la EM
New publication from MSIF on ethical use of off-label DMTs receives global endorsement
Cómo las diversas terapias modificadoras de la enfermedad pueden retrasar el avance
A new study examined different disease modifying therapies and their ability to slow the onset of secondary progressive MS.
Un estudio demuestra una mejora en los resultados de la situación laboral con EM
New research, involving 874 people who had used disease-modifying therapies during the previous 5 years, has shown a link between more effective disease-modifying therapies and an increased level of employment, work attendance and productivity at work.